Pancreatic oncofetal antigen (POA) , pancreatic cancer-associated antigen (PCAA)
Shimano, T.; Takami, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 452-454
1999
ISSN/ISBN: 0047-1852 PMID: 10778162 Document Number: 507325
Document emailed within 1 workday
Related Documents
Kawa, S.; Oguchi, H.; Homma, T. 1986: Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 3). POA (pancreatic oncofetal antigen) Nihon Rinsho. Japanese Journal of Clinical Medicine 44(8): 1821-1824Takami, H.; Hishinuma, S.; Shintoku, J.; Ogata, Y.; Abe, O. 1985: Diagnostic usefulness of serum levels of pancreatic oncofetal antigen (POA) and CA 19-9 in pancreatic cancers: monitoring of postoperative recurrences Gan no Rinsho. Japan Journal of Cancer Clinics 31(6 Suppl): 631-637
Homma, T. 1983: Pancreatic oncofetal antigen (POA)--its characterization and the result of enzyme immunoassay Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(2 Part 2): 617-622
Gelder, F.B.; Reese, C.J.; Moossa, A.R.; Hall, T.; Hunter, R. 1978: Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen Cancer Research 38(2): 313-324
Sujino, H.; Nagamori, S.; Fujise, K.; Hasumura, S.; Homma, S.; Matsuura, T.; Shimizu, K.; Niiya, M.; Kameda, H. 1988: Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen Human Cell 1(2): 250-255
Kim, Y.S.; Itzkowitz, S.H.; Yuan, M.; Chung, Y.; Satake, K.; Umeyama, K.; Hakomori, S. 1988: Lex and Ley antigen expression in human pancreatic cancer Cancer Research 48(2): 475-482
Ban, T.; Imai, K.; Yachi, A. 1989: Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen MUSE11 Cancer Research 49(24 Part 1): 7141-7146
Samoĭlenko, V.M.; Afrikian, M.N.; Itin, A.B. 1989: The diagnostic information value of determining tumor-associated antigen Ca-19-9 in pancreatic cancer Voprosy Onkologii 35(9): 1050-1053
Yamada, T.; Ohwada, S.; Saitoh, F.; Adachi, M.; Morishita, Y.; Hozumi, M. 1996: Induction of Ley antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells Anticancer Research 16(2): 735-740
Kokhanenko, N.I.; Ignashov, A.M.; Varga, E.V.; Polkanova, M.S.; Aleshina, L.A.; Kimbarovskaia, A.A.; Osipenko, S.K.; Lebedev, E.G. 2001: Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer Voprosy Onkologii 47(3): 294-297
Dang, C.-X.; Han, Y.; Qin, Z.-Y.; Wang, Y.-J. 2002: Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer Hepatobiliary and Pancreatic Diseases International: Hbpd Int 1(2): 302-305
Magnani, J.L.; Steplewski, Z.; Koprowski, H.; Ginsburg, V. 1983: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin Cancer Research 43(11): 5489-5492
Kozu, T.; Imaizumi, T.; Hanyu, F.; Takeuchi, T.; Nakamura, K.; Oi, I.; Toki, F.; Fukushima, Y.; Tomatsu, S.; Yoshikawa, T. 1983: Carcinoembryonic antigen (CEA), serum amylase and pancreozymin-secretin test in relation to stages of pancreatic cancer Gan no Rinsho. Japan Journal of Cancer Clinics 29(10): 1104-1110
Yue, H.; Song, F.-L.; Zhang, N.; Feng, X.-L.; An, T.-Y.; Yu, J.-P. 2003: Expression of p27(kip1), Rb protein and proliferating cell nuclear antigen and its relationship with clinicopathology in human pancreatic cancer Hepatobiliary and Pancreatic Diseases International: Hbpd Int 2(1): 142-146
Sakurabayashi, I.; Yamada, T.; Kawai, T.; Yamanaka, T. 1986: Clinical evaluation of a pancreatic cancer-associated glycoprotein antigen, DU-PAN-2. I. Enzymeimmunoassay and distribution of serum values in healthy persons Rinsho Byori. Japanese Journal of Clinical Pathology 34(6): 705-710
Harmenberg, U.; Wahren, B.; Wiechel, K.L. 1988: Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract Cancer Research 48(7): 1985-1988
Lygidakis, N.J.; Papadopoulou, P. 1995: Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Hepato-Gastroenterology 42(5): 587-596
Niewiadomska, H.; Mirowski, M.; Stempien, M.; Olborski, B.; Blonski, J.Z.; Hanausek, M.; Wierzbicki, R. 1998: A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients Neoplasma 45(4): 216-222
Santander, C.; Jiménez, I.; Martín, E.; Melón, A.; Pajares, J.M. 1994: Is the carbohydrate antigen Ca 19.9 useful in the diagnosis of pancreatic carcinoma? Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 86(5): 819-821
Pezzilli, R.; Bertaccini, A.; Billi, P.; Zanarini, L.; Miglio, F.; Martorana, G. 1999: Serum prostate-specific antigen in pancreatic disease Italian Journal of Gastroenterology and Hepatology 31(7): 580-583